Are the Long-Acting Intramuscular Formulations of Risperidone or Paliperidone Palmitate Associated with Post-Injection Delirium/Sedation Syndrome? An Assessment of Safety Databases

By  

Current Drug Safety, Vol. 6, Iss. 1, 2011-02 ,pp. : 43-45

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia

By Witte Michael M.   Case Michael G.   Schuh Kory J.   Ascher-Svanum Haya  

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 315-323

Informa Healthcare

Access to resources Recommend Favorite

Real-world use patterns of olanzapine long-acting injection in the United States: comparison to the recommended dosing strategy

By Case Michael G.   Karagianis Jamie L.   Schuh Kory J.   Hoffmann Vicki Poole  

Current Medical Research and Opinion, Vol. 29, Iss. 11, 2013-11 ,pp. : 1533-1537

Informa Healthcare

Access to resources Recommend Favorite

Optimization of formulation variables for the development of long acting microsphere based depot injection of olanzapine

By Nahata T.   Saini T. R.  

Journal of Microencapsulation, Vol. 25, Iss. 6, 2008-01 ,pp. : 426-433

Informa Healthcare

Access to resources Recommend Favorite

Survey of Victorian ophthalmologists who use ranibizumab to treat age‐related macular degeneration: to identify current practice and modifiable risk factors relevant to post‐injection endophthalmitis

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 43, Iss. 3, 2015-04 ,pp. : 277-279

John Wiley & Sons Inc

Access to resources Recommend Favorite